Neurorehabilitation for Parkinson's disease

Parkinson's Disease (PD) is a common neurodegenerative disorder, resulting in both motor and non-motor symptoms that significantly reduce the quality of life. Treatment consists of both pharmaceutical and non-pharmaceutical treatment approaches. Neurorehabilitation is an important non-pharmaceutical treatment approach, and a prime component of this is formed by the training of behavioral adaptations that can assist patients to cope better with their motor and non-motor symptoms. PD is a chronic neurodegenerative disease which is characterized by the cardinal symptoms akinesia, rigidity, rest tremor and postural instability. These symptoms affect locomotion and, as the disease progresses, can lead to an increased risk of falling. Neurorehabilitative interventions have been used for some time in the treatment of Parkinson disease but, until recently, there has been little evidence to support the clinical impression that physiotherapy, occupational therapy, and speech and language therapy have a positive impact on both motor and non-motor symptoms. 74–98% of patients with Parkinson’s disease will develop sleep problems require neurorehabilitation.